A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
Probuphine (buprenorphine implant) is an implant placed just below the skin containing
buprenorphine (BPN). BPN is an approved treatment for opioid dependence. This study will
confirm the efficacy of Probuphine vs. placebo and compare Probuphine treatment verses
treatment with sublingual buprenorphine in the treatment of patients with opioid dependence.
Phase:
Phase 3
Details
Lead Sponsor:
Titan Pharmaceuticals
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination